Featured Get To Know
Stefan H. Kappe, PhD:
Pioneering Vaccine Solutions To Global Diseases
Distinguished parasitologist and immunologist Stefan Kappe, PhD, recently became the new Director of the UM School of Medicine’s Center for Vaccine Development and Global Health (CVD) and the Myron M. Levine, MD, DTPH Professor of Vaccinology and Vice Chair for Research in the Department of Pediatrics. During his work at the University of Washington and Seattle Children’s Research Institute, he pioneered the use of genetic engineering to develop live attenuated vaccines against the deadly malaria parasites that sicken hundreds of millions of people and kill up to a million people worldwide each year.
More Get To Know and Other Faculty News >
What's the Buzz? are Faculty Awards and Achievements from faculty members, postdoctoral fellows, and students to inform Public Affairs/Media Relations about news that may be of interest to colleagues or the general public.
Featured Press Releases
UM Greenebaum Comprehensive Cancer Center is First in Region to Offer Innovative Cell Therapy for Synovial Sarcoma
The University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC) is the first in the Maryland, Delaware, Virginia, and Washington D.C. region to offer an innovative cell therapy treatment for patients with an advanced type of soft tissue cancer, known as synovial sarcoma. This single-infusion T-cell therapy, called TCR-T therapy, involves engineering a patient’s own white blood cells to recognize and attack cancer cells.
Read More >
First-in-Human Clinical Trial Shows Promising Results for New Lassa Fever Vaccine
Researchers at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health (CVD) reported encouraging results from an early clinical trial that tested a new dual vaccine against Lassa fever and rabies. The study, published today in the journal Nature Medicine, found that the vaccine was safe and induced immune responses against both viruses. There are currently no vaccines against Lassa fever on the market.
Read More >
